Corporate Information And Statement Of Ifrs Compliance [Abstract]

Zealand Pharma - Filing #5889383

Concept	As at 2024-12-31	2024-01-01 to 2024-12-31	As at 2023-12-31
Corporate information and statement of IFRS compliance [abstract]
Legal form of entity	—	A/S	—
Address of entity's registered office	—	Sydmarken	—
Principal place of business	—	Denmark	—
Description of nature of entity's operations and principal activities	—	Nature	—
Statement of IFRS compliance [text block]	—	The	—
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [text block]	—	—	—
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [abstract]
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [line items]
Current inventories	10,698,000 DKK	—	7,935,000 DKK
Current trade receivables	193,559,000 DKK	—	97,803,000 DKK
Current trade payables	254,843,000 DKK	—	125,071,000 DKK
Disclosure of objectives, policies and processes for managing capital [text block]	—	4	—